Current issues in chronic graft-versus-host disease
Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …
complication of allogeneic hematopoietic stem cell transplantation. Increased …
How we treat chronic graft-versus-host disease
MED Flowers, PJ Martin - Blood, The Journal of the American …, 2015 - ashpublications.org
Chronic graft-versus-host disease (GVHD) remains a common and potentially life-
threatening complication of allogeneic hematopoietic stem cell transplantation (HCT). The 2 …
threatening complication of allogeneic hematopoietic stem cell transplantation (HCT). The 2 …
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and …
MH Jagasia, HT Greinix, M Arora, KM Williams… - Biology of Blood and …, 2015 - Elsevier
Abstract The 2005 National Institutes of Health (NIH) Consensus Conference proposed new
criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD) …
criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD) …
EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Several international recommendations address the assessment of graft-versus-host
disease (GvHD) after hematopoietic cell transplantation (HCT). This position statement by …
disease (GvHD) after hematopoietic cell transplantation (HCT). This position statement by …
Interleukin-2 and regulatory T cells in graft-versus-host disease
Background Dysfunction of regulatory T (Treg) cells has been detected in diverse
inflammatory disorders, including chronic graft-versus-host disease (GVHD). Interleukin-2 is …
inflammatory disorders, including chronic graft-versus-host disease (GVHD). Interleukin-2 is …
[HTML][HTML] Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
D Wolff, M Schleuning, S von Harsdorf, U Bacher… - Biology of Blood and …, 2011 - Elsevier
Steroid refractory chronic graft-versus-host disease (cGVHD) is associated with a significant
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …
[HTML][HTML] Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD
Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell
transplantation is still associated with significant morbidity and mortality. First-line treatment …
transplantation is still associated with significant morbidity and mortality. First-line treatment …
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
AC Vigorito, PV Campregher, BE Storer… - Blood, The Journal …, 2009 - ashpublications.org
Historically, graft-versus-host disease (GVHD) beyond 100 days after hematopoietic cell
transplantation (HCT) was called chronic GVHD, even if the clinical manifestations were …
transplantation (HCT) was called chronic GVHD, even if the clinical manifestations were …
[HTML][HTML] Ibrutinib for chronic graft-versus-host disease after failure of prior therapy: 1-year update of a phase 1b/2 study
Chronic graft-versus-host disease (cGVHD) is a life-threatening complication of allogeneic
stem cell transplantation. In a Phase 1b/2, open-label study (PCYC-1129; ClinicalTrials. gov …
stem cell transplantation. In a Phase 1b/2, open-label study (PCYC-1129; ClinicalTrials. gov …
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
S Arai, M Jagasia, B Storer, X Chai… - Blood, The Journal …, 2011 - ashpublications.org
Abstract In 2005, the National Institutes of Health Consensus Development Project on
Criteria for Clinical Trials in Chronic GVHD proposed a new scoring system for individual …
Criteria for Clinical Trials in Chronic GVHD proposed a new scoring system for individual …